Alterity Therapeutics (ATHE) Change in Cash (2016 - 2019)

Alterity Therapeutics' Change in Cash history runs 4 years deep, the most recent figure standing at -$1.6 million for Q4 2019.

• On a quarterly basis, Change in Cash rose 68.41% year-over-year to -$1.6 million in Q4 2019; TTM through Dec 2019 was -$8.2 million, a 72.08% decrease from a year earlier, with the FY2025 full-year figure at $13.3 million, up 692.99% from the prior year.
• Change in Cash rose to -$1.6 million in Q4 2019 per ATHE's latest filing, from -$5.1 million in the prior quarter.
• Across five years, Change in Cash topped out at -$598231.8 in Q4 2016 and bottomed at -$5.1 million in Q4 2018.
• The 4-year median for Change in Cash is -$1.3 million (2017), against an average of -$2.1 million.
• Across the five-year window, Change in Cash tumbled 444.27% in 2018 and surged 68.41% in 2019, its largest moves.
• Year by year, Change in Cash stood at -$598231.8 in 2016, then slumped by 56.04% to -$933486.7 in 2017, then tumbled by 444.27% to -$5.1 million in 2018, then jumped by 68.41% to -$1.6 million in 2019.
• Per Business Quant, the three latest ATHE Change in Cash figures stand at -$1.6 million (Q4 2019), -$5.1 million (Q4 2018), and -$933486.7 (Q4 2017).